Licensing Opportunities Skinvisible operates as an R&D pharmaceutical company focused on licensing its patented Invisicare technology and related topical and transdermal products. This creates a sales pathway for potential licensees in international and multinational pharma, biotech, and consumer goods sectors seeking new products or lifecycle management for existing portfolios.

Dermatology Product Line The portfolio spans obesity, acne, warts, rare skin diseases, sunscreens, anti aging, hand sanitizers, and pre surgical preparations, indicating multiple entry points for dermatology brands, medical distributors, and contract manufacturers looking to expand in skin health and preventive care.

Strategic Partnerships Past licensing activity with Quoin Pharmaceuticals demonstrates a cadence of global collaboration. This suggests a favorable environment for co development, licensing deals, or exclusive regional rights with partners seeking accelerated market access.

Growth via OEM/Co Development With a lean company size and revenue in the low to mid single digits, there is potential for OEM manufacturing or co development arrangements with larger contract manufacturers or pharma companies aiming to leverage Invisicare technology without building internal R&D infrastructure.

Market Expansion Readiness Active online presence and IT stack (cloud, ecommerce, CRM, marketing automation) support rapid go to market and digital partnerships. This positions Skinvisible to onboard distributors, digital health platforms, or consumer retailers seeking skin care, sunscreens, or preventive therapies leveraging patented tech.